Back to Search
Start Over
Dual Inhibition of DPP-4 and Cholinesterase Enzymes by the Phytoconstituents of the Ethanolic Extract of Prosopis cineraria Pods: Therapeutic Implications for the Treatment of Diabetes-associated Neurological Impairments.
- Source :
-
Current Alzheimer research [Curr Alzheimer Res] 2019; Vol. 16 (13), pp. 1230-1244. - Publication Year :
- 2019
-
Abstract
- Background: Insulin resistance causes decreased uptake of glucose which promotes the susceptibility of type 2 associated neurological impairments.<br />Methods: The study was aimed to evaluate the inhibition potential of the ethanolic extract of Prosopis cineraria (EPC) pods against DPP-4 and cholinesterase enzymes by in-vitro, in-vivo and in-silico assessments. The present study consists of in vivo studies on a diabetes-induced rat model by HOMA (Homeostasis model assessment) and related parameters, in vitro studies through the DPP-4 enzyme assay and cholinesterase assays using Ellman's reaction. The in-silico studies were conducted by the molecular docking of Cinerin C with targeted enzymes. The phytochemical characterization of the extract was demonstrated through LCMS studies. The antioxidant studies on the extract were performed by FRAP and TEAC assays.<br />Results: The extract showed 64.8% maximum inhibition of DPP-4, 34.91% inhibition of AChE and 74.35% inhibition of BuChE. The antioxidant capacity of the extract was observed to be 847.81±16.25μM Fe2+ equivalent in the FRAP assay and 0.40 ± 0.08 mmol/l of Trolox equivalent in the TEAC assay. The in vivo study showed competent glycaemic control against significant HOMA IR (1.5), HOMA % β (26.5) and HOMA % S (68.8) as well as pancreatic cell mass proliferation. The insilico analysis also revealed positive interactions of Cinerin C with targeted enzymes (DPP4 and cholinesterase).<br />Conclusion: It can be concluded that the phytoconstituents of Prosopis cineraria pod extract can be significantly considered in neuropharmacology to resolve insulin resistance-induced neurological complications as it showed inhibition against DPP-4, AChE and BuChE target enzymes.<br /> (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Subjects :
- Animals
Antioxidants chemistry
Antioxidants pharmacology
Cholinesterase Inhibitors chemistry
Diabetes Mellitus, Experimental drug therapy
Diabetes Mellitus, Experimental enzymology
Diabetes Mellitus, Experimental pathology
Ethanol chemistry
Molecular Docking Simulation
Nervous System Diseases enzymology
Nervous System Diseases etiology
Nervous System Diseases pathology
Pancreas drug effects
Pancreas pathology
Phytochemicals chemistry
Phytochemicals pharmacology
Plant Extracts chemistry
Rats
Cholinesterase Inhibitors pharmacology
Diabetes Mellitus, Experimental complications
Dipeptidyl-Peptidase IV Inhibitors pharmacology
Nervous System Diseases drug therapy
Plant Extracts pharmacology
Prosopis
Subjects
Details
- Language :
- English
- ISSN :
- 1875-5828
- Volume :
- 16
- Issue :
- 13
- Database :
- MEDLINE
- Journal :
- Current Alzheimer research
- Publication Type :
- Academic Journal
- Accession number :
- 31797759
- Full Text :
- https://doi.org/10.2174/1567205016666191203161509